Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
PLoS Pathog ; 20(3): e1012011, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38427609

RESUMEN

Candida auris is an emerging fungal pathogen with unusual evolutionary history-there are multiple distinct phylogeographic clades showing a near simultaneous transition from a currently unknown reservoir to nosocomial pathogen. Each of these clades has experienced different selective pressures over time, likely resulting in selection for genotypes with differential fitness or phenotypic consequences when introduced to new environments. We also observe diversification within clades, providing additional opportunities for phenotypic differences. These differences can have large impacts on pathogenic potential, drug resistance profile, evolutionary trajectory, and transmissibility. In recent years, there have been significant advances in our understanding of strain-specific behavior in other microbes, including bacterial and fungal pathogens, and we have an opportunity to take this strain variation into account when describing aspects of C. auris biology. Here, we critically review the literature to gain insight into differences at both the strain and clade levels in C. auris, focusing on phenotypes associated with clinical disease or transmission. Our goal is to integrate clinical and epidemiological perspectives with molecular perspectives in a way that would be valuable for both audiences. Identifying differences between strains and understanding which phenotypes are strain specific will be crucial for understanding this emerging pathogen, and an important caveat when describing the analysis of a singular isolate.


Asunto(s)
Evolución Biológica , Candida auris , Fenotipo , Genotipo , Hospitales
2.
Science ; 381(6665): 1461-1467, 2023 09 29.
Artículo en Inglés | MEDLINE | ID: mdl-37769084

RESUMEN

Candida auris is an emerging fungal pathogen responsible for health care-associated outbreaks that arise from persistent surface and skin colonization. We characterized the arsenal of adhesins used by C. auris and discovered an uncharacterized adhesin, Surface Colonization Factor (Scf1), and a conserved adhesin, Iff4109, that are essential for the colonization of inert surfaces and mammalian hosts. SCF1 is apparently specific to C. auris, and its expression mediates adhesion to inert and biological surfaces across isolates from all five clades. Unlike canonical fungal adhesins, which function through hydrophobic interactions, Scf1 relies on exposed cationic residues for surface association. SCF1 is required for C. auris biofilm formation, skin colonization, virulence in systemic infection, and colonization of inserted medical devices.


Asunto(s)
Candida auris , Candidiasis Invasiva , Proteínas Fúngicas , Proteínas de Microfilamentos , Animales , Humanos , Candida auris/genética , Candida auris/patogenicidad , Virulencia , Candidiasis Invasiva/microbiología , Proteínas Fúngicas/química , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Proteínas de Microfilamentos/química , Proteínas de Microfilamentos/genética , Proteínas de Microfilamentos/metabolismo , Dominios Proteicos , Interacciones Hidrofóbicas e Hidrofílicas , Ratones
4.
Nat Commun ; 12(1): 7197, 2021 12 10.
Artículo en Inglés | MEDLINE | ID: mdl-34893621

RESUMEN

Candida auris is an emerging healthcare-associated pathogen of global concern. Recent reports have identified C. auris isolates that grow in cellular aggregates or filaments, often without a clear genetic explanation. To investigate the regulation of C. auris morphogenesis, we applied an Agrobacterium-mediated transformation system to all four C. auris clades. We identified aggregating mutants associated with disruption of chitin regulation, while disruption of ELM1 produced a polarized, filamentous growth morphology. We developed a transiently expressed Cas9 and sgRNA system for C. auris that significantly increased targeted transformation efficiency across the four C. auris clades. Using this system, we confirmed the roles of C. auris morphogenesis regulators. Morphogenic mutants showed dysregulated chitinase expression, attenuated virulence, and altered antifungal susceptibility. Our findings provide insights into the genetic regulation of aggregating and filamentous morphogenesis in C. auris. Furthermore, the genetic tools described here will allow for efficient manipulation of the C. auris genome.


Asunto(s)
Candida auris/citología , Candida auris/genética , Candida auris/fisiología , Proteínas Fúngicas/genética , Morfogénesis/genética , Genética Inversa , Animales , Antifúngicos/farmacología , Sistemas CRISPR-Cas , Candida auris/efectos de los fármacos , Candidiasis/microbiología , Modelos Animales de Enfermedad , Farmacorresistencia Fúngica/efectos de los fármacos , Fluconazol , Regulación Fúngica de la Expresión Génica , Morfogénesis/efectos de los fármacos , Mariposas Nocturnas , Mutación , Proteínas Quinasas/genética , Virulencia
5.
Curr Protoc Microbiol ; 59(1): e124, 2020 12.
Artículo en Inglés | MEDLINE | ID: mdl-33108055

RESUMEN

Candida albicans is a common mucosal colonizer, as well as a cause of lethal invasive fungal infections. The major predisposing factor for invasive fungal disease is a compromised immune system. One component of the host immune response to fungal infection is the activation of the inflammasome, a multimeric protein complex that is critical for regulating host pro-inflammatory responses. Here, we describe methods for investigating the interactions between C. albicans and host macrophages, with a focus on the inflammasome. C. albicans isolates differ in the degree to which they activate the inflammasome due to differences in internalization, morphogenic switching, and inflammasome priming. Therefore, we include protocols for identifying these factors. This simple in vitro model can be used to elucidate the contributions of specific C. albicans strains or mutants to different aspects of interactions with macrophages. © 2020 Wiley Periodicals LLC. Basic Protocol 1: Measuring inflammasome priming in response to Candida albicans Basic Protocol 2: Measuring inflammasome activation in response to Candida albicans Support Protocol: Controlling for phagocytosis.


Asunto(s)
Candida albicans/metabolismo , Interacciones Huésped-Patógeno/fisiología , Inflamasomas/metabolismo , Candidiasis/microbiología , Macrófagos/microbiología , Técnicas de Tipificación Micológica/métodos , Fagocitosis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA